NCT06479733

Brief Summary

The aim of the study is to evaluate the efficacy of different soft tissue grafting techniques including buccal pedicle flap alone, free connective tissue graft and acellular dermal matrix for volumetric augmentation of peri-implant mucosa during the second stage implant surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2023

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 22, 2024

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

June 23, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 28, 2024

Completed
Last Updated

June 28, 2024

Status Verified

June 1, 2024

Enrollment Period

12 months

First QC Date

June 23, 2024

Last Update Submit

June 23, 2024

Conditions

Keywords

soft tissue, augmentation, dental implants, connective tissue graft, alloderm, buccal pedicle flap

Outcome Measures

Primary Outcomes (2)

  • Clinical measurement of soft tissue thickness

    At the baseline surgical visit, after local anesthetic administeration, the buccal peri-implant mucosal thickness (PMT) will be measured and recorded. An endodontic spreader will be gently inserted through the the surface of the mucosa to the bone, then the thickness measured by the spreader will be recorded using a digital caliper. The procedure will be reapeated after complete healing of the tissue

    6 months

  • Esthetic evaluation

    According to Furhauser et al., 2005, esthetic scoring index called pink esthetic score (PES) index will be used in the current study. Seven points of evaluation (mesial papilla, distal papilla, soft tissue margins, soft tissue contouring, alveolar process, soft tissue color and soft tissue texture) of score 0,1,2: this index uses a maximum score of 14, representing optimum esthetic outcome with respect to the peri-implant soft tissue conditions. The PES index fulfilled important characteristics as inclusion of the peri-implant soft tissue and the restoration-inherent parameters.

    6 months

Secondary Outcomes (2)

  • modified gingival index

    6 months

  • modified plaque index

    6 months

Study Arms (4)

Group I (buccal pedicle flap group):

ACTIVE COMPARATOR

Includes 7 implants that will receive implants with soft tissue augmentation using buccal pedicle flap only.

Procedure: buccal pedicle flap

Group II (free CTG group):

ACTIVE COMPARATOR

Includes 7 implants that will receive implants with soft tissue augmentation using free CTG.

Procedure: connective tissue graft

Group III (ADM group):

ACTIVE COMPARATOR

Includes 7 implants that will receive implants with soft tissue augmentation using acellular dermal matrix.

Procedure: acellular dermal matrix

Group IV (control group):

SHAM COMPARATOR

Includes 7 implants that will receive implants without soft tissue augmentation.

Procedure: control group

Interventions

For the first group (buccal pedicle flap group), outlining the full-thickness palatal flap 1 mm greater than the diameter of the underlying cover screw will be done, making a partial incision at the hinge portion of the created mini-pedicle flap to facilitate buccal rolling, de-epithelializing the mini-pedicle flap, then two small vertical incisions will be performed similarly mesial and distal to the screw border as wide as possible preserving the papilla and extending labially to include all the keratinized mucosa, elevating a full-thickness flap, then rolling of the pedicle flap into the created buccal pouch. The flap will be then sutured all around in place using a 5/0 vicryl suture

Group I (buccal pedicle flap group):

For the second group (free CTG group), masticatory mucosa on the palate between palatal raphae and maxillary posterior teeth is the most common location for the donor site for free CTG. It will be obtained by harvesting and de-epithelializing FGG asbeing a CTG derived from de-epithelialization of FGG mainly composed of lamina propria. Then the donor site will be covered by gel foam , sutured and protected.

Group II (free CTG group):

* For the third group (ADM group) , The matrix will be trimmed so that it is gently adapted to the artificial envelope created on the buccal aspect of the ridge.The matrix will be trimmed and beveled to make its adaptation into the artificial envelope easier. Before placement, matrix will be hydrated for 10 minutes in fresh human blood collected after flap elevation in each patient. * For both second and third groups, graft will be carefully positioned under the buccal pouch, sutured to it, light pressure will be applied over the inserted graft with moist gauze for 10 minutes to minimize blood clot and dead space formation between the graft and the underlying bone.

Group III (ADM group):
control groupPROCEDURE

only placement of dental implant without soft tissue augmentation

Group IV (control group):

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient age : above 20 years with single or multiple edentulous spaces
  • Healthy periodontium.
  • Thin periodontal phenotype.
  • Non smoker.
  • Adequate amount of basal bone to achieve primary stability.
  • Patient who is able to understand and sign a written consent.
  • Patient with good oral hygiene measures and plaque index\<1

You may not qualify if:

  • Presence of systemic , local disease or any medication that would compromise healing.
  • Presence of infection or pathology related to the surgical area.
  • Pregnancy and lactation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

faculty of Dentistry , Mansoura University

Al Mansurah, DK, 35516, Egypt

Location

MeSH Terms

Interventions

Control Groups

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Ghada A. Elhusseiny, PHD

    Mansoura University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
B.D.S (Mansoura University, 2014) Assistant lecturer at Oral Medicine, Periodontology , Diagnosis and Oral Radiology department (2021)

Study Record Dates

First Submitted

June 23, 2024

First Posted

June 28, 2024

Study Start

June 1, 2023

Primary Completion

May 15, 2024

Study Completion

June 22, 2024

Last Updated

June 28, 2024

Record last verified: 2024-06

Locations